- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decision
October 21, 2022
From MarketWatch
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
WHO says another omicron subvariant, which may be more resistant to antibodies, spread to 26 countries in latest week
October 20, 2022
From MarketWatch
Short Interest Sector Focus: Healthcare Sector
October 20, 2022
From Benzinga
Why Moderna Stock Dropped Today
October 19, 2022
From Motley Fool
Why Novavax Stock Couldn't Win on Wednesday
October 19, 2022
From Motley Fool
What's Going On With Novavax Shares Spiking Higher Today
October 19, 2022
Tickers
NVAX
From Benzinga
More Likely to Double First: Teladoc or Novavax?
October 19, 2022
From Motley Fool
Why BioNTech SE And Novavax Shares Are Diving
October 18, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2022
From Benzinga
Got $300? 3 Genius Stocks to Buy on the Dip
October 18, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 17, 2022
From Benzinga
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
October 16, 2022
From Motley Fool
Why Novavax Stock Had an Ugly Friday
October 14, 2022
From Motley Fool
Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15%
October 14, 2022
From Benzinga
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
October 13, 2022
From MarketWatch
KnowBe4 (KNBE) Stock Jumps 12% on Take-Private Deal
October 12, 2022
From InvestorPlace
Long COVID is a ‘very serious’ crisis, says head of WHO as he urges world leaders to act now
October 12, 2022
Tickers
NVAX
Tags
NVAX
From MarketWatch
Why Is Novavax (NVAX) Stock in the Spotlight Today?
October 12, 2022
From InvestorPlace
5 Investors Betting Big on Novavax (NVAX) Stock
October 11, 2022
From InvestorPlace
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
October 11, 2022
Tickers
NVAX
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.